As one of the world's most essential sectors, pharma is responsible for developing and delivering life-saving medicines to billions of patients, but it also carries a substantial environmental footprint. From energy-intensive manufacturing processes to complex global supply chains and meeting shifting regulatory concerns, the industry's operations generate significant carbon emissions and consume vast amounts of natural resources.
Fortunately, the tide is turning, and pharmaceutical sustainability has emerged as both a moral imperative and a business priority that shapes investment decisions, regulatory frameworks, and consumer expectations. What’s more, the urgency is undeniable. According to research published around last year's COP30 summit, [1] the pharmaceutical industry's greenhouse gas emissions outpaced those of the automotive industry by 55%, while even running 13% ahead of global aviation. For an industry dedicated to improving human health, this environmental impact presents a profound contradiction that demands immediate action.


